Pharmaceuticals, Biotechnology and Life Sciences
Sanofi and DiCE Molecules has announced a five-year global collaboration to discover potential new therapeutics for up to 12 targets that encompass all disease areas of strategic interest to Sanofi.
FDA warns public about eye drop bottles with loose safety seals
Drug maker Valeant faces debt default risk; shares plunge 50 percent
Lilly includes a single primary endpoint of cognition (ADAS-Cog14) to EXPEDITION3 trial
Verona Pharma reports positive results from RPL554 dose-finding study
MedMined Surveillance Advisor named “the best technology for Infection Control and Monitoring”
On January 28, 2016, the United States Food and Drug Administration (FDA) approved Zepatier (elbasvir and grazoprevir) for the treatment of chronic genotype 1 or 4 hepatitis C virus (HCV) infection in adults.
J&J has annonced that results of a new analysis of data from real-world clinical practice show that, in adults with type 2 diabetes
Scientists have long been interested in how the vascular system — the body’s network of large and small blood vessels — may be involved in the onset and progression of Alzheimer’s disease and related dementias.
Ethicon, a medical device company of the Johnson & Johnson family of companies, has announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.